Literature DB >> 20021175

The state of polio vaccination in the world: the case for continuing routine vaccination.

Mark R Geier1, David A Geier.   

Abstract

This article reviews the literature concerning polio vaccination and uses that information to evaluate the World Health Organization's announced plans to end polio vaccination early in the 21st century. The safe elimination of polio vaccination would require the elimination of all polio cases, including paralytic cases, mild, nonparalytic cases, and vaccine-associated cases; proof that polio does not have any nonhuman alternative host; proof that no one alive can still shed the poliovirus; proof that no poliovirus persists in the environment; and proof that no live poliovirus, either the wild type or the vaccine strain, exists in medical or terrorist hands. Because it does not seem possible to ensure that ending vaccination against polio would be safe, and given the fact the polio is a terrible and untreatable disease, it would seem prudent to continue polio vaccination for the foreseeable future.

Entities:  

Year:  2002        PMID: 20021175     DOI: 10.1080/15376520208951158

Source DB:  PubMed          Journal:  Toxicol Mech Methods        ISSN: 1537-6516            Impact factor:   2.987


  9 in total

1.  A case-control study evaluating the relationship between thimerosal-containing haemophilus influenzae type b vaccine administration and the risk for a pervasive developmental disorder diagnosis in the United States.

Authors:  David A Geier; Janet K Kern; Paul G King; Lisa K Sykes; Mark R Geier
Journal:  Biol Trace Elem Res       Date:  2014-11-11       Impact factor: 3.738

2.  Thimerosal exposure and increased risk for diagnosed tic disorder in the United States: a case-control study.

Authors:  David A Geier; Janet K Kern; Brian S Hooker; Paul G King; Lisa K Sykes; Kristin G Homme; Mark R Geier
Journal:  Interdiscip Toxicol       Date:  2015-06

3.  Thimerosal-containing Hepatitis B Vaccine Exposure is Highly Associated with Childhood Obesity: A Case-control Study Using the Vaccine Safety Datalink.

Authors:  David A Geier; Janet K Kern; Kristin G Homme; Lisa K Sykes; Mark R Geier
Journal:  N Am J Med Sci       Date:  2016-07

4.  Abnormal Brain Connectivity Spectrum Disorders Following Thimerosal Administration: A Prospective Longitudinal Case-Control Assessment of Medical Records in the Vaccine Safety Datalink.

Authors:  David A Geier; Janet K Kern; Kristin G Homme; Mark R Geier
Journal:  Dose Response       Date:  2017-03-16       Impact factor: 2.658

5.  A Cross-Sectional Study of the Association between Infant Hepatitis B Vaccine Exposure in Boys and the Risk of Adverse Effects as Measured by Receipt of Special Education Services.

Authors:  David A Geier; Janet K Kern; Kristin G Homme; Mark R Geier
Journal:  Int J Environ Res Public Health       Date:  2018-01-12       Impact factor: 3.390

6.  Premature Puberty and Thimerosal-Containing Hepatitis B Vaccination: A Case-Control Study in the Vaccine Safety Datalink.

Authors:  David A Geier; Janet K Kern; Mark R Geier
Journal:  Toxics       Date:  2018-11-15

7.  A dose-response relationship between organic mercury exposure from thimerosal-containing vaccines and neurodevelopmental disorders.

Authors:  David A Geier; Brian S Hooker; Janet K Kern; Paul G King; Lisa K Sykes; Mark R Geier
Journal:  Int J Environ Res Public Health       Date:  2014-09-05       Impact factor: 3.390

8.  Thimerosal-Preserved Hepatitis B Vaccine and Hyperkinetic Syndrome of Childhood.

Authors:  David A Geier; Janet K Kern; Brian S Hooker; Lisa K Sykes; Mark R Geier
Journal:  Brain Sci       Date:  2016-03-15

9.  A cross-sectional study of the relationship between reported human papillomavirus vaccine exposure and the incidence of reported asthma in the United States.

Authors:  David A Geier; Janet K Kern; Mark R Geier
Journal:  SAGE Open Med       Date:  2019-01-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.